MRNA Oct 2022 220.000 put
| Previous close | 46.13 |
| Open | 46.13 |
| Bid | 52.20 |
| Ask | 52.85 |
| Strike | 220.00 |
| Expiry date | 2022-10-21 |
| Day's range | 46.13 - 46.13 |
| Contract range | N/A |
| Volume | |
| Open interest | 413 |
- Editor's pickYahoo Finance Video
UK approves COVID vaccine that targets Omicron subvariants
Yahoo Finance reporter Anjalee Khemlani details how the U.K. has approved a vaccine that targets both the original and omicron variants of the coronavirus.
- Motley Fool
Why Moderna Stock Is Sliding Today
What happened Shares of Moderna (NASDAQ: MRNA) had slid 4.2% lower at 11:26 a.m. ET on Tuesday after being down as much as 5.8% earlier in the day. The company didn't announce any negative news. However, there were a couple of factors that could be behind the decline.
- Motley Fool
Why Moderna Stock Climbed Today
Shares of Moderna (NASDAQ: MRNA) rose 3.3% on Monday after health regulators in the U.K. authorized the biopharmaceutical leader's bivalent COVID-19 vaccine booster for use in adults. Moderna's updated vaccine targets the original coronavirus strain and the currently fast-spreading omicron variants. On Monday, the Medicines and Healthcare products Regulatory Agency (MHRA) said the new bivalent booster meets its "standards of safety, quality, and effectiveness."
